Purui Bright Eye Hospital Confirms RMB $200 Valuation Under the Strategic Investment from China Life Big Health Fund

China ophthalmology chain hospital, Purui Bright Eye Hospital has welcomed RMB $200 million investment from China Life Big Health Fund. The fresh funds will plan to reinforce the cooperation partnership between both parties. It is estimated that the company valuation will be around RMB $2.2 billion after the strategic investment confirmation.

Founded in 2005, Purui has extended its business category to plenty of ophthalmology treatment solutions, including Cataract, Glaucoma and so on. Currently, Purui has already set up 18 ophthalmology-related hospitals in Shanghai, Beijing, Chengdu, Kunming, Hefei, Lanzhou, Wuhan, and Urumqi. Meanwhile, it is preparing for the hospital construction in Nanjing and Guangzhou. With its outstanding team up from 400 experts and 3,000 staffs, Purui stands in a leading position in the industry. Moreover, it owns 7 cornea basements for the better eyes care.

In the current state, Purui has partnershiped with Peking Union Medical College Hospital and ophthalmology division of Zhongshan University. In the future, it will bring in more cutting-edge equipment’s and provide a personalized surgery with the back of high-tech and science-proved technology for the better treatments for the patients.

國壽大健康基金戰略獨投 普瑞眼科估值將達22億

中國眼科連鎖醫療機構普瑞眼科獲得國壽大健康基金獨家投資2億元人民幣，在獲得中國人壽的戰略加持後，將進一步加強雙方的產業合作，預估普瑞眼科的投後估值將高達22億元。

普瑞眼科成立於2005年，提供白內障、青光眼等眼科全科診療項目，在上海、北京、成都、昆明、合肥、蘭州、武漢、烏魯木齊等城市共開設18家大型眼科專科醫院，南京、廣州醫院亦正籌備中，精英專家團隊近400人，員工總數超3,000人，是中國境內少數擁有專業眼病研究所、7家眼角膜庫等的專業連鎖眼科機構。

普瑞眼科已與協和醫院、中山眼科等國內外專業眼科醫療機構、學術機構以及設備廠家建立緊密合作關係，並持續引進大批高端設備，為個性化手術診療提供了科學高效的技術支撐，為患者帶來高品質、高保障的診療服務及體驗。